Open Access

Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?

Journal of Neuroinflammation201512:68

https://doi.org/10.1186/s12974-015-0290-z

Received: 4 March 2015

Accepted: 4 March 2015

Published: 9 April 2015

The original article was published in Journal of Neuroinflammation 2014 11:198

Erratum

After publication of our article [1], it came to our attention that we had erroneously stated that the IVIG product NewGam was produced by Sutter Health. However, Octapharma is the manufacturer of NewGamTM and Sutter Health is the sponsor of the clinical trial. Therefore the following sentence on page 2 of the original manuscript [1] is incorrect: "The effects of Sutter Health's IVIG NewGamTM are also being examined in individuals with mild cognitive impairment (MCI) [33], thought to be the transitional state between the cognitive changes of normal aging and very early dementia [34]." This sentence should read as follows: “The effects of Octapharma's IVIG NewGamTM are also being examined in individuals with mild cognitive impairment (MCI) [33], thought to be the transitional state between the cognitive changes of normal aging and very early dementia [34].”

Notes

Declarations

Authors’ Affiliations

(1)
Department of Internal Medicine, Division of Neurology, Beaumont Health System

Reference

  1. Loeffler DA. Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered? J Neuroinflammation. 2014;11:198.PubMed CentralPubMedGoogle Scholar

Copyright

© Loeffler; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement